Literature DB >> 33630100

[Deep brain stimulation in neurological and psychiatric diseases].

Stephan Klebe1, Volker Coenen2.   

Abstract

Invasive deep brain stimulation (DBS) has become an established treatment procedure for a number of neurological diseases, especially movement disorders. The number of patients treated with DBS is continuously increasing, the technical development of DBS systems is progressing and new indications are currently being tested in studies. This review gives an overview of the current indications and an outlook on future developments of DBS in movement disorders and psychiatric diseases.

Entities:  

Keywords:  Dystonia; Parkinsons Disease; Psychiatric diseases; Target selection; Tremor

Year:  2021        PMID： 33630100     DOI： 10.1007/s00115-021-01079-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


  60 in total

1.  Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition.

Authors:  Cameron C McIntyre; Warren M Grill; David L Sherman; Nitish V Thakor
Journal:  J Neurophysiol       Date:  2003-12-10       Impact factor: 2.714

2.  Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases.

Authors:  E Svennilson; A Torvik; R Lowe; L Leksell
Journal:  Acta Psychiatr Scand       Date:  1960       Impact factor: 6.392

3.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

Authors:  L V Laitinen; A T Bergenheim; M I Hariz
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

Review 4.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

5.  Axonal failure during high frequency stimulation of rat subthalamic nucleus.

Authors:  Fang Zheng; Katja Lammert; Barbara E Nixdorf-Bergweiler; Frank Steigerwald; Jens Volkmann; Christian Alzheimer
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

6.  Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study.

Authors:  Martin M Reich; Andreas Horn; Florian Lange; Jonas Roothans; Steffen Paschen; Joachim Runge; Fritz Wodarg; Nicolo G Pozzi; Karsten Witt; Robert C Nickl; Louis Soussand; Siobhan Ewert; Virgina Maltese; Matthias Wittstock; Gerd-Helge Schneider; Volker Coenen; Philipp Mahlknecht; Werner Poewe; Wilhelm Eisner; Ann-Kristin Helmers; Cordula Matthies; Volker Sturm; Ioannis U Isaias; Joachim K Krauss; Andrea A Kühn; Günther Deuschl; Jens Volkmann
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

7.  Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus.

Authors:  A L Benabid; P Pollak; C Gervason; D Hoffmann; D M Gao; M Hommel; J E Perret; J de Rougemont
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

8.  Stimulation site within the MRI-defined STN predicts postoperative motor outcome.

Authors:  Fritz Wodarg; Jan Herzog; René Reese; Daniela Falk; Markus O Pinsker; Frank Steigerwald; Olav Jansen; Günther Deuschl; H Maximillian Mehdorn; Jens Volkmann
Journal:  Mov Disord       Date:  2012-04-19       Impact factor: 10.338

9.  Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.

Authors:  P Limousin; P Pollak; A Benazzouz; D Hoffmann; J F Le Bas; E Broussolle; J E Perret; A L Benabid
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

10.  Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Authors:  Eugénie Lhommée; Lars Wojtecki; Virginie Czernecki; Karsten Witt; Franziska Maier; Lisa Tonder; Lars Timmermann; Thomas D Hälbig; Fanny Pineau; Franck Durif; Tatiana Witjas; Marcus Pinsker; Maximilian Mehdorn; Friederike Sixel-Döring; Andreas Kupsch; Rejko Krüger; Saskia Elben; Stephan Chabardès; Stéphane Thobois; Christine Brefel-Courbon; Fabienne Ory-Magne; Jean-Marie Regis; David Maltête; Anne Sauvaget; Jörn Rau; Alfons Schnitzler; Michael Schüpbach; Carmen Schade-Brittinger; Gunther Deuschl; Jean-Luc Houeto; Paul Krack
Journal:  Lancet Neurol       Date:  2018-03       Impact factor: 44.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.